# CONEXXENCE
> **BLA761398** · Biologics License Application · Sponsor: FRESENIUS KABI USA LLC · Approved 2025-03-25
## Drug
- **FDA Application Number:** BLA761398
- **Application type:** Biologics License Application
- **Brand name:** CONEXXENCE
- **Generic name:** DENOSUMAB
- **Active ingredients:** DENOSUMAB-BNHT
- **Dosage form:** INJECTION
- **Route:** —
- **Marketing status:** Prescription
- **Sponsor:** FRESENIUS KABI USA LLC
- **Manufacturer:** Fresenius Kabi USA, LLC
- **First approval:** 2025-03-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761398)
---
*AI Analytics · CC0 1.0*